Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for improving drug resistance of escherichia coli and application thereof

A technology of Escherichia coli and drug resistance, which is applied in the fields of genetic engineering and medical engineering, and can solve problems such as product safety hazards and microbial contamination

Active Publication Date: 2021-07-27
JIANGNAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antimicrobial resistance in E. coli leads to microbial contamination and safety concerns for product consumption, study finds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving drug resistance of escherichia coli and application thereof
  • Method for improving drug resistance of escherichia coli and application thereof
  • Method for improving drug resistance of escherichia coli and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Embodiment 1: Construction of knockout plasmid

[0046] Using the CRISPR / Cas9 knockout system to knock out flagella and pilus synthesis and transport gene clusters, four knockout plasmids need to be constructed: pTargetF-flhD-motA, pTargetF-fliY-fliR, pTargetF-flgN-flgL, pTargetF-fimB-fimH , the construction process of the plasmid is as follows:

[0047] (1) Select 20nt N complementary to the target sequence of the target gene 20 sequence, specific N 20 The sequences are the underlined sequences of the primers pTargetF-flhE-motA-F, pTargetF-fliY-fliR-F, pTargetF-flgN-flgL-F, and pTargetF-fimB-fimH-F, and these sequences are modified into the plasmid pTargetF forward primer At the 5' end, forward primers pTargetF-flhD-motA-F, pTargetF-fliY-fliR-F, pTargetF-flgN-flgL-F, and pTargetF-fimB-fimH-F were respectively obtained. Using the plasmid pTargetF as a template, the forward primers pTargetF-flhD-motA-F, pTargetF-fliY-fliR-F, pTargetF-flgN-flgL-F, pTargetF-fimB-fimH-F,...

Embodiment 2

[0054] Embodiment 2: Construction of genetically engineered bacteria WJW010 and WJW011

[0055] The CRISPR / Cas9 knockout system was used to knock out the flagella synthesis and transport gene cluster of wild-type Escherichia coli W3110 to obtain engineering strain WJW010; the pili gene cluster was knocked out to get WJW011. The specific knockout process is as follows:

[0056] (1) Preparation of Escherichia coli electroporation knockout competent

[0057] The plasmid pCas is transformed into Escherichia coli W3110 to obtain recombinant Escherichia coli W3110 / pCas containing the pCas plasmid, and the Escherichia coli W3110 / pCas is activated on the LB solid plate adding 30mg / L Kanamycin (Kan), and inoculated into LB +Kan test tube cultured overnight to obtain seed liquid; transfer the seed liquid to 25mL LB+Kan medium at 1%, and cultivate to OD at 30°C and 200rpm 600 =0.2, add 500 μL L-arabinose solution to induce, continue to culture to OD 600 =0.5, ice bath for 30min; 4°C, ...

Embodiment 3

[0069] Example 3: Drug patch experiment of strains WJW010, WJW011 and wild-type strain W3110

[0070] Specific steps are as follows:

[0071] (1) Escherichia coli W3110 (hereinafter referred to as W3110), flagella gene knockout strain WJW010 and pili knockout strain WJW011 were inoculated into LB liquid medium respectively, and cultured at 37°C and 200rpm for 12h to prepare seed liquid;

[0072] (2) The prepared seed liquid was measured by initial OD 600 =0.2 Transfer to fresh LB liquid medium, cultivate to logarithmic phase OD at 37°C, 200rpm 600 =1.0, the bacterial suspension was prepared;

[0073] (3) Draw 100 μL of the bacterial suspension obtained in step (2) and spread evenly on the LB solid medium respectively. Stick it to the corresponding position, mark it, incubate it in a 37°C incubator for 24 hours, take pictures, and observe the inhibition zone; among them, the results of the cefoxitin drug susceptibility test are shown in Table 3 and figure 1 Shown:

[0074]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for improving drug resistance of escherichia coli and application of the method, and belongs to the field of gene engineering and fermentation engineering. According to the invention, three flagellum gene clusters flhE-motA, fliY-fliR and flgN-flgL on an escherichia coli genome are knocked out to obtain a simplified flagellum strain WJW010, and a pilus gene cluster fimB-fimH is knocked out to obtain a pilus simplified strain WJW011. The knockout of flagellum or pilus synthetic gene clusters can reduce the drug resistance to cefoxitin, and the MICs of WJW010 and WJW011 to cefoxitin are 8 mg / L and 8 mg / L respectively and are reduced by one time compared with that of wild control bacteria W3110; in addition, by knocking out the flagellum gene cluster or the pilus gene cluster, the acetyl coenzyme A and ATP synthesis level can be improved; and experiments show that the levels of synthesizing acetyl coenzyme A and ATP (adenosine triphosphate) from WJW010 and WJW011 are higher than those of wild control W3110.

Description

technical field [0001] The invention relates to a method for improving Escherichia coli drug resistance and application thereof, belonging to the fields of genetic engineering and medical engineering. Background technique [0002] Cefoxitin is a second-generation cephalosporin antibiotic belonging to the β-lactam antibiotic group. Cefoxitin kills β-bacteria by inhibiting bacterial cell wall synthesis and is highly resistant to β-lactamase produced by bacteria. At present, due to the increasing bacterial resistance to cephalosporins, cefoxitin, which is different from the first-generation and third-generation cephalosporins and is stable to β-lactamase, has once again attracted people's attention and has huge market potential. Cephalosporins have a wide antibacterial spectrum and low toxicity, and are widely used in livestock and poultry breeding. When cephalosporins are discharged into the soil and sewage through sewage discharge in industrial production, or feces discharg...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/52C12N15/70A61K45/00A61P31/04C12R1/19
CPCC12N15/52C12N15/70A61K45/00A61P31/04Y02A50/30
Inventor 王小元王建莉马文渐梁浩朱怡炫
Owner JIANGNAN UNIV